These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22687392)

  • 1. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for apathy in Alzheimer's disease.
    Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
    Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
    J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
    Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
    Clipp EC; Moore MJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study.
    Dubois B; McKeith I; Orgogozo JM; Collins O; Meulien D
    Int J Geriatr Psychiatry; 1999 Nov; 14(11):973-82. PubMed ID: 10556869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
    Brodaty H; Corey-Bloom J; Potocnik FC; Truyen L; Gold M; Damaraju CR
    Dement Geriatr Cogn Disord; 2005; 20(2-3):120-32. PubMed ID: 15990426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of galantamine treatment on caregiver time in Alzheimer's disease.
    Sano M; Wilcock GK; van Baelen B; Kavanagh S
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):942-50. PubMed ID: 14533127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
    Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil therapy for apathy in an elderly patient.
    Padala PR; Burke WJ; Bhatia SC
    Ann Pharmacother; 2007 Feb; 41(2):346-9. PubMed ID: 17264158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
    Antuono PG
    Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
    Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P;
    J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.